Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistNature's Innovation, Inc. was cited for selling unapproved new drugs, specifically the "Naturasil Molluscum Treatment Kit" and "Naturasil Shingles" products, through their website and social media channels in violation of section 505(a) of the Federal Food, Drug, and Cosmetic Act. The FDA found particular concern with the molluscum treatment product being marketed for use in children, a condition that requires professional medical evaluation to rule out serious conditions such as skin cancer and fungal infections, and for which no legally marketed over-the-counter treatments exist. The company failed to obtain FDA approval before introducing these drug products into interstate commerce, and the marketing of these products could lead consumers to forgo or delay proper medical diagnosis and care.